FostiRel
is recombinant follitropin beta stimulating
hormone (r-FSH). FSH is a fertility
hormone that is responsible for folliculogenesis
and ovulation in females . It also indicated
for spermatogenesis in males
Amongst females with infertility, ovulatory
problems like anovulation are responsible
for around 25% of cases, while in case
of males, azoospermia or oligzoospermia
are most prominent contributing reasons.
Recombinant FSH, since it is a pure
protein product, containing only FSH
and no contaminants, subcutaneous administration
is advocated. In this case, the pharmacokinetics
does not seem to be affected. Subcutaneous
administration, in fact, improves the
patient compliance.
FostiRel is available as multi dose
vials in strengths of 300 IU, 900 IU
and 1200 IU. Multiple tests prove the
product to be exactly similar to the
innovator, in terms of product identity
and purity.
